In the Conference Coverage section of the CLL Society website, we’ve posted an interview with Dr. Andrew Roberts from a discussion we had about the new data on Venetoclax used in combination with Rituximab for relapsed refractory CLL. You can find the interview on our front page.
On Saturday, October 29th I will be in San Francisco, CA. More details in the flyer cllsociety.org/docs/EventFl... . I will be speaking immediately following the unbranded live event. My effort will be to try to get a support group in the bay area, so please come by and say hello if you are interested. I'll be hanging around after for a bit. Flying in in the AM, home in the PM. Too much travel!
In the meantime….
We are all in this together.